152 related articles for article (PubMed ID: 26687634)
1. 2-Acetyl-7-hydroxy-6-methoxy-1-methyl-1,2,3,4,-tetrahydroisoquinoline exhibits anti-inflammatory properties and protects the nigral dopaminergic neurons.
Son HJ; Han SH; Lee JA; Lee CS; Seo JW; Chi DY; Hwang O
Eur J Pharmacol; 2016 Jan; 771():152-61. PubMed ID: 26687634
[TBL] [Abstract][Full Text] [Related]
2. A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP.
Son HJ; Lee JA; Shin N; Choi JH; Seo JW; Chi DY; Lee CS; Kim EM; Choe H; Hwang O
Br J Pharmacol; 2012 Apr; 165(7):2213-27. PubMed ID: 21951056
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson's disease.
Wang S; Jing H; Yang H; Liu Z; Guo H; Chai L; Hu L
J Ethnopharmacol; 2015 Apr; 164():247-55. PubMed ID: 25666429
[TBL] [Abstract][Full Text] [Related]
4. Potential repositioning of exemestane as a neuroprotective agent for Parkinson's disease.
Son HJ; Han SH; Lee JA; Shin EJ; Hwang O
Free Radic Res; 2017 Jun; 51(6):633-645. PubMed ID: 28770670
[TBL] [Abstract][Full Text] [Related]
5. Attenuation of neuroinflammatory responses and behavioral deficits by Ligusticum officinale (Makino) Kitag in stimulated microglia and MPTP-induced mouse model of Parkinson's disease.
Kim BW; Koppula S; Park SY; Kim YS; Park PJ; Lim JH; Kim IS; Choi DK
J Ethnopharmacol; 2015 Apr; 164():388-97. PubMed ID: 25449453
[TBL] [Abstract][Full Text] [Related]
6. Biochanin A Protects Against Lipopolysaccharide-Induced Damage of Dopaminergic Neurons Both In Vivo and In Vitro via Inhibition of Microglial Activation.
Wang J; Wu WY; Huang H; Li WZ; Chen HQ; Yin YY
Neurotox Res; 2016 Oct; 30(3):486-98. PubMed ID: 27417698
[TBL] [Abstract][Full Text] [Related]
7. Acorus gramineus inhibits microglia mediated neuroinflammation and prevents neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model of Parkinson's disease.
Jiang J; Kim JJ; Kim DY; Kim MK; Oh NH; Koppula S; Park PJ; Choi DK; Shin YK; Kim IH; Kang TB; Lee KH
J Ethnopharmacol; 2012 Dec; 144(3):506-13. PubMed ID: 23085397
[TBL] [Abstract][Full Text] [Related]
8. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
9. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
10. A Novel Compound ITC-3 Activates the Nrf2 Signaling and Provides Neuroprotection in Parkinson's Disease Models.
Lee JA; Son HJ; Park KD; Han SH; Shin N; Kim JH; Kim HR; Kim DJ; Hwang O
Neurotox Res; 2015 Nov; 28(4):332-45. PubMed ID: 26233727
[TBL] [Abstract][Full Text] [Related]
11. A novel pyrazolo [3,4-d] pyrimidine, KKC080106, activates the Nrf2 pathway and protects nigral dopaminergic neurons.
Lee JA; Kim HR; Son HJ; Shin N; Han SH; Cheong CS; Kim DJ; Hwang O
Exp Neurol; 2020 Oct; 332():113387. PubMed ID: 32580013
[TBL] [Abstract][Full Text] [Related]
12. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
[TBL] [Abstract][Full Text] [Related]
13. Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.
Wilms H; Zecca L; Rosenstiel P; Sievers J; Deuschl G; Lucius R
Curr Pharm Des; 2007; 13(18):1925-8. PubMed ID: 17584117
[TBL] [Abstract][Full Text] [Related]
14. Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson's Disease in Rats.
Chen G; Liu J; Jiang L; Ran X; He D; Li Y; Huang B; Wang W; Fu S
Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267220
[TBL] [Abstract][Full Text] [Related]
15. Montelukast treatment protects nigral dopaminergic neurons against microglial activation in the 6-hydroxydopamine mouse model of Parkinson's disease.
Jang H; Kim S; Lee JM; Oh YS; Park SM; Kim SR
Neuroreport; 2017 Mar; 28(5):242-249. PubMed ID: 28178069
[TBL] [Abstract][Full Text] [Related]
16. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice.
Costa T; Fernandez-Villalba E; Izura V; Lucas-Ochoa AM; Menezes-Filho NJ; Santana RC; de Oliveira MD; Araújo FM; Estrada C; Silva V; Costa SL; Herrero MT
J Neuroimmune Pharmacol; 2021 Jun; 16(2):390-402. PubMed ID: 32564332
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine prevents loss of nigrostriatal dopaminergic neurons by inhibiting brain inflammation and oxidative stress in an experimental model of Parkinson's disease.
Chung YC; Kim SR; Jin BK
J Immunol; 2010 Jul; 185(2):1230-7. PubMed ID: 20566832
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
[TBL] [Abstract][Full Text] [Related]
19. A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model.
Lee JA; Son HJ; Kim JH; Park KD; Shin N; Kim HR; Kim EM; Kim DJ; Hwang O
Free Radic Res; 2016; 50(11):1188-1199. PubMed ID: 27598306
[TBL] [Abstract][Full Text] [Related]
20. Induction of NQO1 and Neuroprotection by a Novel Compound KMS04014 in Parkinson's Disease Models.
Son HJ; Choi JH; Lee JA; Kim DJ; Shin KJ; Hwang O
J Mol Neurosci; 2015 Jun; 56(2):263-72. PubMed ID: 25702135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
